Reimbursement Support
Reimbursement Codes and Allowables
Reimbursement Guide
Patient Education
Prostate Diseases
Patient FAQs
Patient Information from Package Insert
Androgen Reduction Graph
Physician Information


  Bayer Global
  Bayer Corporate - USA
general conditions of use
privacy statement
imprint
© 2007 Bayer HealthCare Pharmaceuticals

 
Physician Support
Patient Education		    
     
 

Patients and their families frequently think of questions about their condition and/or treatment after they have left the office. This section is designed to help the busy physician or health care professional provide a take-home sheet with fast answers to their patients’ questions on prostate issues.

These sheets print easily on standard-size copy paper and contain information from reliable medical sources, such as the American Cancer Society and the National Institutes of Health. Each sheet leaves room for you to record your own instructions or allow the patient to take notes.

These sheets are not a replacement for patient-doctor communications, but rather a value-added service you can provide. You should encourage patients to contact you or your nurse should any medical issues or concerns arise.

From the selections below or at left, simply click on an article title to obtain your patient education material:

Prostate Diseases
  Patient FAQs  
  Androgen Reduction Graph  
  Patient-Friendly Package Insert  
 
American Cancer Society
 

National Institutes of Health

Important Safety Considerations
Viadur is contraindicated in patients with hypersensitivity to Gn-RH, Gn-RH agonist analogs, or any of the components in Viadur.

Viadur is contraindicated in women and pediatric patients and was not studied in women or children.

Viadur, like other LH-RH agonists, causes a transient increase in serum concentrations of testosterone during the first week of treatment. Patients may experience a worsening of symptoms or onset of new symptoms including bone pain, neuropathy, hematuria, or ureteral or bladder outlet obstruction, and spinal cord compression.

The most comment systemic side effects were hot flashes (67.9%), asthenia (7.6%), gynecomastia (6.9%), depression (5.3%), and sweating (5.3%). The most common local side effects were bruising (34.6%) and burning (5.6%).

Distributed and Marketed by:
Manufactured by:

Bayer HealthCare Pharmaceuticals
6 West Belt, Wayne, NJ 07470 USA

© Copyright 2007 Bayer HealthCare Pharmaceuticals. Viadur is a trademark of ALZA Corporation under license to Bayer HealthCare Pharmaceuticals. DUROS® is a registered trademark of ALZA Corporation.

The information provided on Bayer products is only intended for the United States audience. Regulatory requirements, regulations, laws, and distribution of information about drug products may vary from country to country. Product names and indications (product uses) also may be different in different countries. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the United States.